Organ Manufacturing Coop

Posted on 7/21/2026

United Therapeutics Corporation

United Therapeutics Corporation

No salary listed

Manchester, NH, USA

In Person

Onsite at Manchester, New Hampshire for the entire duration; no relocation assistance provided.

California, US residentsclick here.

The job details are as follows:

Who We Are

We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.

United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).

The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.

United Therapeutics does not provide relocation assistance, housing, or transportation. The selected Co-op will need to be onsite at the Manchester, NH office for the entire duration of this co-op role (4o hours a week), from as soon as possible through of December 2026.

Who You Are

What if your next research project helped build the future of organ transplantation? As a PhD Co-op on our Organ Manufacturing team, you'll work at the cutting edge of biomaterials, tissue engineering, and 3D bioprinting, helping advance technologies designed to create transplantable lungs. From optimizing hydrogel scaffolds and peptide conjugation strategies to developing novel analytical assays, you'll contribute to ambitious science with the potential to transform patient care. If you're energized by complex challenges, hands-on experimentation, and turning bold ideas into reality, this is an opportunity you won't want to miss.

 1) Post-processing (e.g. washing, surface modification etc.) of 3D printed hydrogel scaffolds.

2) Optimizing and performing peptide conjugation studies on 3D printed hydrogel scaffolds.

3) Developing and optimizing analytical assays for quantification of peptides conjugated on 3D printed hydrogel scaffolds.

4) Developing and performing assays to study peptide stability at multiple storage and sampling conditions.

Coops are educational positions requiring basic knowledge and understanding of (bio)material science fundamentals, 3D printing processes, tissue engineering, and manufacturing to support research and development in production of 3D-printed lung scaffolds suitable for recellularization. This coop will include a project/deliverable that will be completed during employment and will utilize academic foundations to further career aspirations.

  • Develop, evaluate and/or improve formulation designs for new and ongoing projects under the direct
  • supervision of assigned engineering scientist
  • Assist with basic project management, including development of a project plan and schedule
  • Generate comprehensive protocols for testing/analyzing the materials during development
  • Generate design assurance and comprehensive report documentation for testing and characterization
  • Develop, evaluate and/or improve methods for cellularization of 3D printed scaffold designs for new and
  • ongoing projects
  • Assist and perform setup and maintenance for cellularization studies
  • Assessment of cell phenotype, behavior and health following cellularization studies
  • Assessment of cell viability, cell phenotype, and cell or tissue function following cellularization studies
  • Communicate cross-functionally with members of the Organ Manufacturing Group and other company
  • functions as needed
  • Perform other duties as assigned

Minimum Requirements

  • Candidate must be an actively enrolled student in an academic program for the duration of the assignment; pursuing a PhD degree in Chemistry, Biochemistry, Chemical Engineering, Biomedical Engineering, Material Science, Tissue Engineering or related discipline
  • Experience with analytical assay development and optimization using advanced analytical techniques such as
  • HPLC, Mass Spectrometry etc.
  • Knowledge of basic statistical analysis tools and techniques

Preferred Qualifications

  • GPA of 3.5 or higher
  • Experience working with basic confocal microscopy
  • Experience with mechanical testing of hydrogel materials
  • Experience working with fluidic systems optimizing micro- and macro-scale flow patterns
  • Experience with chemical characterization of hydrogel materials

Job Location

This coop position is based fully onsite in Manchester, NH.

Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities

United Therapeutics  Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.